Profile data is unavailable for this security.
About the company
SINTX Technologies, Inc. is an advanced ceramics company. The Company is focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. The Company is focusing primarily on the research, development and commercialization of medical devices manufactured with silicon nitride. The Company is manufacturing, research, and development of products comprised from advanced ceramic materials for external partners. It produces silicon nitride for use in its commercial products and product candidates in various forms: solid silicon nitride, porous silicon nitride, silicon nitride powder, composites of silicon nitride and PEEK and PEKK and silicon nitride coating. It is also focused on development and manufacturing ceramics for personnel, aircraft, and vehicle armor. Its silicon nitride products can be polished to a smooth and wear-resistant surface for articulating applications, such as bearings for hip and knee replacements.
- Revenue in USD (TTM)3.13m
- Net income in USD-8.60m
- Incorporated1996
- Employees43.00
- LocationSINTX Technologies Inc1885 West 2100 StreetSALT LAKE CITY 84119United StatesUSA
- Phone+1 (801) 839-3516
- Fax+1 (801) 839-3605
- Websitehttps://sintx.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NanoVibronix Inc | 3.37m | -2.82m | 1.92m | 10.00 | -- | 0.6762 | -- | 0.5696 | -1.32 | -1.32 | 1.50 | 1.02 | 0.7081 | 0.431 | 12.05 | 337,300.00 | -59.12 | -116.16 | -122.41 | -169.36 | 64.57 | 50.47 | -83.49 | -570.47 | 1.16 | -14.77 | 0.00 | -- | 203.59 | 48.33 | 31.88 | -- | -34.02 | -- |
| BIOLASE Inc | 46.10m | -36.19m | 2.01m | 157.00 | -- | -- | -- | 0.0437 | -11.65 | -11.65 | 3.32 | -0.0636 | 1.31 | 2.55 | 8.73 | 293,611.50 | -54.64 | -49.28 | -185.36 | -85.80 | 33.01 | 35.27 | -41.65 | -50.72 | 0.3589 | -6.00 | 1.19 | -- | 1.45 | 1.27 | -30.39 | -- | 18.63 | -- |
| Avinger Inc | 7.43m | -15.34m | 2.19m | 68.00 | -- | 0.2361 | -- | 0.2952 | -12.13 | -12.13 | 5.83 | 4.05 | 0.434 | 1.23 | 8.03 | 109,250.00 | -113.20 | -70.93 | -1,387.68 | -131.57 | 19.96 | 30.87 | -260.86 | -208.91 | 1.20 | -11.66 | 0.3428 | -- | -7.51 | -0.6736 | 32.76 | -- | -24.21 | -- |
| Arch Therapeutics Inc | 148.17k | -12.99m | 2.27m | 8.00 | -- | -- | -- | 15.30 | -3.69 | -3.69 | 0.0383 | -2.83 | 0.10 | 0.0662 | -- | 18,521.25 | -828.03 | -188.28 | -- | -804.63 | 39.58 | -- | -8,276.08 | -26,945.92 | 0.0051 | -1.32 | -- | -- | 383.83 | -- | -32.35 | -- | -21.76 | -- |
| Nuwellis Inc | 9.01m | -22.81m | 2.35m | 59.00 | -- | -- | -- | 0.261 | -181.60 | -181.60 | 48.48 | -13.25 | 0.8292 | 1.52 | 7.30 | 152,779.70 | -192.57 | -98.07 | -301.19 | -122.48 | 60.28 | 55.22 | -232.24 | -230.51 | 0.7119 | -1.52 | -- | -- | 3.76 | 12.14 | -55.78 | -- | 4.61 | -- |
| Optimus Healthcare Services Inc | 1.89m | -7.16m | 2.46m | 12.00 | -- | -- | -- | 1.30 | -0.1744 | -0.1744 | 0.0454 | -0.1889 | 1.26 | -- | 3.67 | 157,291.70 | -477.28 | -- | -- | -- | 85.93 | -- | -379.51 | -- | -- | -5.42 | -- | -- | 22.88 | -- | -3.51 | -- | -- | -- |
| Sonendo Inc | 37.46m | -47.49m | 2.50m | 216.00 | -- | 0.14 | -- | 0.0668 | -0.5017 | -0.4436 | 0.3952 | 0.2453 | 0.498 | 1.95 | 6.91 | 173,421.30 | -63.14 | -- | -78.26 | -- | 35.04 | -- | -126.79 | -- | 1.73 | -8.54 | 0.5194 | -- | 5.30 | -- | -6.78 | -- | -- | -- |
| Vycor Medical Inc | 1.36m | -506.30k | 2.58m | 8.00 | -- | -- | -- | 1.90 | -0.0155 | -0.0156 | 0.0417 | -0.1081 | 1.43 | 0.6694 | 5.08 | 170,011.30 | -19.13 | -47.86 | -- | -- | 89.23 | 89.60 | -13.38 | -35.42 | 0.0987 | -0.8001 | -- | -- | 19.43 | -0.6542 | 46.49 | -- | -31.77 | -- |
| SINTX Technologies Inc | 3.13m | -8.60m | 2.59m | 43.00 | -- | 0.2927 | -- | 0.8271 | -271.52 | -271.52 | 16.44 | 11.82 | 0.1818 | 1.77 | 7.63 | 72,697.67 | -50.01 | -45.71 | -62.67 | -57.36 | 67.72 | 58.47 | -275.14 | -681.80 | 1.79 | -- | 0.0265 | -- | 68.29 | 94.24 | 49.75 | -- | 54.10 | -- |
| Helius Medical Technologies Inc | 594.00k | -8.84m | 2.61m | 22.00 | -- | 0.4116 | -- | 4.39 | -10.68 | -10.68 | 0.5042 | 1.98 | 0.0606 | 0.7486 | 4.48 | 27,000.00 | -90.17 | -98.37 | -110.33 | -143.57 | 12.79 | 37.27 | -1,487.54 | -1,580.66 | 3.80 | -- | 0.00 | -- | -18.17 | 6.14 | 37.11 | -- | -41.95 | -- |
| Invo Bioscience Inc | 5.77m | -7.08m | 2.72m | 25.00 | -- | -- | -- | 0.4706 | -3.24 | -3.24 | 2.44 | 0.3529 | 0.4677 | 12.00 | 34.74 | 230,781.20 | -57.44 | -94.63 | -116.03 | -151.45 | 44.89 | 74.91 | -122.80 | -343.11 | 0.2686 | -4.75 | 0.6588 | -- | 267.38 | 43.62 | 26.24 | -- | 87.09 | -- |
| Heart Test Laboratories Inc | 18.60k | -7.29m | 2.73m | 15.00 | -- | 0.4568 | -- | 146.82 | -5.65 | -5.65 | 0.0011 | 6.55 | 0.0035 | 0.0092 | -- | 1,240.00 | -135.14 | -- | -193.38 | -- | 67.31 | -- | -39,193.76 | -- | 4.02 | -20.72 | 0.0777 | -- | 261.17 | -- | -3.95 | -- | -- | -- |
| Acutus Medical Inc | 9.55m | -9.70m | 2.97m | 233.00 | -- | -- | -- | 0.3113 | -0.3301 | 0.0956 | 0.3261 | -0.1353 | 0.1211 | 1.14 | 1.46 | 40,974.25 | -12.30 | -46.76 | -14.84 | -56.88 | -24.07 | -89.12 | -101.56 | -773.49 | 2.89 | -4.64 | 1.13 | -- | 136.36 | 27.03 | -141.35 | -- | -35.99 | -- |
| Tenon Medical Inc | 3.37m | -13.87m | 3.09m | 21.00 | -- | -- | -- | 0.9169 | -39.79 | -39.79 | 9.45 | 1.76 | 0.4252 | 2.27 | 5.27 | 160,571.40 | -174.87 | -- | -495.99 | -- | 60.32 | -- | -411.27 | -- | 1.02 | -- | 0.00 | -- | 323.73 | -- | 17.63 | -- | -- | -- |
| ReShape Lifesciences Inc | 8.05m | -9.02m | 3.29m | 31.00 | -- | 1.08 | -- | 0.4091 | -1.29 | -1.29 | 0.4766 | 0.1033 | 0.882 | 0.8035 | 4.79 | 259,548.40 | -98.88 | -136.06 | -169.55 | -194.32 | 67.47 | 56.30 | -112.11 | -408.36 | 0.8875 | -- | 0.00 | -- | -22.79 | -0.9474 | 75.36 | -- | -49.29 | -- |
Data as of Sep 20 2024. Currency figures normalised to SINTX Technologies Inc's reporting currency: US Dollar USD
4.33%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| L1 Capital Global, Inc.as of 25 Mar 2024 | 22.50k | 3.01% |
| UBS Securities LLCas of 30 Jun 2024 | 4.28k | 0.57% |
| Tower Research Capital LLCas of 30 Jun 2024 | 3.09k | 0.41% |
| SignatureFD LLCas of 30 Jun 2024 | 1.15k | 0.15% |
| Citigroup Global Markets, Inc. (Investment Management)as of 30 Jun 2024 | 1.04k | 0.14% |
| Headlands Technologies LLCas of 30 Jun 2024 | 256.00 | 0.03% |
| Qube Research & Technologies Ltd.as of 30 Jun 2024 | 19.00 | 0.00% |
| Morgan Stanley & Co. LLCas of 30 Jun 2024 | 11.00 | 0.00% |
| Bank of America, NA (Private Banking)as of 30 Jun 2024 | 5.00 | 0.00% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 30 Jun 2024 | 2.00 | 0.00% |
More ▼
Data from 30 Jun 2024 - 29 Aug 2024Source: FactSet Research Systems Inc.
